CNCE

Concert Pharmaceuticals, Inc.
CNCE

Overview Fund Activity
Delisted

CNCE was delisted on the 3rd of March, 2023.

Back to rankings

80 hedge funds and large institutions have $227M invested in Concert Pharmaceuticals, Inc. in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 17 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
+10
Holders Change %
+14.29%
% of All Funds
1.38%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
19
Increased
33
Reduced
17
Closed
9
Calls
$1.12M
Puts
$105K
Net Calls
+$1.01M
Net Calls Change
+$464K

Top Buyers

1
TCM
1
Tang Capital Management
California
$6.72M
2
KCM
2
Kynam Capital Management
New Jersey
$11.2M
3
AG
3
Artal Group
Luxembourg
$3.84M
4
Citadel Advisors
4
Citadel Advisors
Florida
$7.51M
5
BlackRock
5
BlackRock
New York
$5.54M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$7.29M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$4.31M
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$4.21M
4
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$4.44M
5
Walleye Capital
5
Walleye Capital
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Barclays
26
Barclays
United Kingdom
$3.03M +$505K +75,341 +20%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$2.74M +$1.1M +164,116 +67%
Two Sigma Investments
28
Two Sigma Investments
New York
$2.47M +$867K +129,476 +54%
EGI
29
EAM Global Investors
California
$2.26M -$346K -51,635 -13%
Goldman Sachs
30
Goldman Sachs
New York
$2.24M +$982K +146,591 +78%
Connor, Clark & Lunn Investment Management (CC&L)
31
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.01M – – –
Point72 Asset Management
32
Point72 Asset Management
Connecticut
$1.81M +$1.81M +270,600 New
SSA
33
Schonfeld Strategic Advisors
New York
$1.74M +$1.34M +199,500 +335%
Invesco
34
Invesco
Georgia
$1.59M +$1.59M +237,277 New
IBT
35
International Biotechnology Trust
United Kingdom
$1.35M +$1.33M +198,190 +7,593%
BCM
36
Bridgeway Capital Management
Texas
$993K – – –
Northern Trust
37
Northern Trust
Illinois
$866K +$215K +32,099 +33%
CANY
38
Caxton Associates (New York)
New York
$832K +$832K +124,115 New
Citigroup
39
Citigroup
New York
$809K +$809K +120,717 New
State Street
40
State Street
Massachusetts
$808K +$125K +18,700 +18%
Bank of New York Mellon
41
Bank of New York Mellon
New York
$806K -$146K -21,836 -15%
SEI Investments
42
SEI Investments
Pennsylvania
$712K -$22.3K -3,326 -3%
CAM
43
ClariVest Asset Management
California
$702K – – –
Ensign Peak Advisors
44
Ensign Peak Advisors
Utah
$592K – – –
JPMorgan Chase & Co
45
JPMorgan Chase & Co
New York
$585K +$275K +41,018 +88%
KIC
46
Kensington Investment Counsel
California
$515K +$3K +447 +0.6%
CSS
47
Cubist Systematic Strategies
Connecticut
$490K -$114K -17,055 -19%
BDF
48
Black Diamond Financial
Maryland
$476K +$13.4K +2,000 +3%
RC
49
RBF Capital
California
$435K -$41.5K -6,198 -9%
OQS
50
Occudo Quantitative Strategies
Florida
$421K +$421K +62,804 New
1
2
3 4